{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1363670319799200640.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1093/brain/awf272"}},{"identifier":{"@type":"URI","@value":"http://academic.oup.com/brain/article-pdf/125/12/2591/1115267/awf272.pdf"}},{"identifier":{"@type":"NAID","@value":"30018522844"}}],"dc:title":[{"@value":"Peripheral neuropathies and anti-glycolipid antibodies"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1583105975487074048","@type":"Researcher","foaf:name":[{"@value":"H. J. Willison"}]}],"publication":{"publicationIdentifier":[{"@type":"EISSN","@value":"14602156"},{"@type":"PISSN","@value":"http://id.crossref.org/issn/00068950"}],"prism:publicationName":[{"@value":"Brain"}],"dc:publisher":[{"@value":"Oxford University Press (OUP)"}],"prism:publicationDate":"2002-12-01","prism:volume":"125","prism:number":"12","prism:startingPage":"2591","prism:endingPage":"2625"},"reviewed":"false","url":[{"@id":"http://academic.oup.com/brain/article-pdf/125/12/2591/1115267/awf272.pdf"}],"createdAt":"2002-11-13","modifiedAt":"2017-08-23","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360004230233992192","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"IgG anti‐Galnac‐GD1a antibodies bind to neuromuscular junctions of rat hemidiaphragm"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004235493003904","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Effects of acidic phospholipids on antiganglioside antibodies in <scp>G</scp>uillain–<scp>B</scp>arré syndrome: Role of the disialosyl residue"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021391856115456","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Cell density-dependent membrane distribution of ganglioside GM3 in melanoma cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285704964210944","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The First Total Synthesis of Ganglioside GalNAc‐GD1a, a Target Molecule for Autoantibodies in Guillain–Barré Syndrome"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285709567654656","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Anti-GM1/GD1a complex antibodies in GBS sera specifically recognize the hybrid dimer GM1-GD1a"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285712874836480","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Neuronal Expression of GalNAc Transferase Is Sufficient to Prevent the Age-Related Neurodegenerative Phenotype of Complex Ganglioside-Deficient Mice"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285713014555008","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Guillain–Barré syndrome: update on immunobiology and treatment"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567182316310400","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Anti-GM1 antibodies affect the integrity of lipid rafts"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567185446788992","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Mechanism and spectrum of anti‐glycolipid antibody‐mediated chronic inflammatory demyelinating polyneuropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848657228500096","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Antibodies to gangliosides and ganglioside complexes in Guillain–Barré syndrome and Fisher syndrome: Mini-review"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848660591531392","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Antibodies against ganglioside complexes in Guillain‐Barré syndrome and related disorders"}]},{"@id":"https://cir.nii.ac.jp/crid/1360857593737223296","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Unclassified subtype of Guillain-Barré syndrome is associated with quick recovery"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204651696512","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Antiganglioside antibodies-Their pathophysiological effects on Guillain-Barre Syndrome and variants-"},{"@language":"ja","@value":"抗ガングリオシド抗体―ギラン・バレー症候群とその関連疾患における病態への関与―"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204681086464","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"多彩な神経症状を呈した小細胞肺癌に伴う傍腫瘍性神経症候群の1例"},{"@language":"en","@value":"A Case of Small Cell Lung Cancer with Diverse Neurological Symptoms due to Paraneoplastic Neurological Syndrome"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204866377216","@type":"Article","resourceType":"エディトリアル(editorial)","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Amyotrophic Lateral Sclerosis with IgM Antibody against Gangliosides GM2 and GD2"},{"@value":"Antibodies to GM2 Ganglioside in Neurological Disorders"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001206410926080","@type":"Article","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Simultaneous immunohistochemical detection of gangliosides and neuronal markers in paraformaldehyde-fixed nervous tissues by acetone etching"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001206445691520","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"8. Inflammatory and Peripheral Nerve Disorder (Autoimmune Peripheral Neuropathy)"},{"@language":"ja","@value":"8．炎症と末梢神経疾患（免疫性末梢神経障害について）"},{"@value":"炎症と末梢神経疾患(免疫性末梢神経障害について)"},{"@language":"ja-Kana","@value":"エンショウ ト マッショウ シンケイ シッカン メンエキセイ マッショウ シンケイ ショウガイ ニ ツイテ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679122732160","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"The role of sulfoglucuronosyl glycosphingolipids in the pathogenesis of monoclonal IgM paraproteinemia and peripheral neuropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679847667072","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Rapidly Progressive Guillain-Barré Syndrome Following <i>Escherichia coli</i> Infection"},{"@value":"Rapidly Progressive Guillain-Barr&eacute; Syndrome Following <i>Escherichia coli</i> Infection"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680017128960","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"尿閉と便秘を随伴し，Fisher症候群にpharyngeal-cervical-brachial variantがオーバーラップした1例"},{"@language":"en","@value":"An overlap case of Fisher syndrome and pharyngeal-cervical-brachial variant of Guillain-Barré syndrome associated with urinary retention and constipation"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680024446080","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"<I>Campylobacter jejuni</I> Enteritis and Guillain-Barré Syndrome"},{"@language":"ja","@value":"<I>Campylobacter jejuni</I>腸炎とギラン・バレー症候群"},{"@value":"Campylobacter jejuni腸炎とギラン・バレー症候群"},{"@language":"ja-Kana","@value":"Campylobacter jejuni チョウエン ト ギラン バレー ショウコウグン"},{"@value":"Campylobacter jejuni感染とギラン・バレー症候群"},{"@language":"ja-Kana","@value":"Campylobacter jejuni カンセン ト ギラン バレー ショウコウグン"},{"@value":"Campylobacter jejuni Enteritis and Guillain-Barr^|^eacute; Syndrome"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282763010841856","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"急性散在性脳脊髄炎と多発神経炎を併発した抗ラクトシルセラミド（LacCer）抗体陽性の1例"},{"@language":"en","@value":"A case of acute disseminated encephalomyelitis concomitant with polyneuropathy associated with anti-lactosylceramide antibody"},{"@value":"A case of acute disseminated encephalomyelitis concomitant with polyneuropathy associated with anti-lactosylceramide antibody (in Japanese)"}]},{"@id":"https://cir.nii.ac.jp/crid/1571135651215591424","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"Pure motor Guillain-Barre 症候群の新規標的抗原 : GM1/GalNAc-GD1a複合体 : 電気生理所見を中心として"},{"@language":"en","@value":"GM1/GalNAc-GD1a complex as a new target antigen of pure motor Guillain-Barre syndrome : electrophysiological aspect"}]},{"@id":"https://cir.nii.ac.jp/crid/1571698599845427072","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"神経･筋疾患"},{"@language":"en","@value":"Advances in Neuroimmunological Laboratory Studies"}]},{"@id":"https://cir.nii.ac.jp/crid/1572261550408336384","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"An adolescent with pharyngeal-cervical-brachial variant of Guillain-Barre syndrome after cytomegalovirus infection"}]},{"@id":"https://cir.nii.ac.jp/crid/1573387450033039232","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"IgM monoclonal gammopathy に合併し抗GD1b抗体陽性を示した慢性感覚性失調性ニューロパチー"},{"@language":"en","@value":"Chronic sensory ataxic neuropathy associated with IgM monoclonal gammopathy and anti-GD1b IgM antibody"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1093/brain/awf272"},{"@type":"CIA","@value":"30018522844"},{"@type":"CROSSREF","@value":"10.1002/mus.23385_references_DOI_UZlFJxrp5wa1AW96evc8JzWXGNL"},{"@type":"CROSSREF","@value":"10.1111/cen3.12002_references_DOI_UZlFJxrp5wa1AW96evc8JzWXGNL"},{"@type":"CROSSREF","@value":"10.2482/haigan.56.199_references_DOI_UZlFJxrp5wa1AW96evc8JzWXGNL"},{"@type":"CROSSREF","@value":"10.1016/j.mcn.2010.07.008_references_DOI_UZlFJxrp5wa1AW96evc8JzWXGNL"},{"@type":"CROSSREF","@value":"10.5692/clinicalneurol.cn-000887_references_DOI_UZlFJxrp5wa1AW96evc8JzWXGNL"},{"@type":"CROSSREF","@value":"10.1007/s00018-023-04813-9_references_DOI_UZlFJxrp5wa1AW96evc8JzWXGNL"},{"@type":"CROSSREF","@value":"10.1002/chem.201003357_references_DOI_UZlFJxrp5wa1AW96evc8JzWXGNL"},{"@type":"CROSSREF","@value":"10.1093/glycob/cwr139_references_DOI_UZlFJxrp5wa1AW96evc8JzWXGNL"},{"@type":"CROSSREF","@value":"10.1586/ern.09.77_references_DOI_UZlFJxrp5wa1AW96evc8JzWXGNL"},{"@type":"CROSSREF","@value":"10.1016/j.jneuroim.2010.02.001_references_DOI_UZlFJxrp5wa1AW96evc8JzWXGNL"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.46.6330_references_DOI_UZlFJxrp5wa1AW96evc8JzWXGNL"},{"@type":"CROSSREF","@value":"10.1111/cen3.12452_references_DOI_UZlFJxrp5wa1AW96evc8JzWXGNL"},{"@type":"CROSSREF","@value":"10.2169/naika.97.539_references_DOI_UZlFJxrp5wa1AW96evc8JzWXGNL"},{"@type":"CROSSREF","@value":"10.2183/pjab.87.386_references_DOI_UZlFJxrp5wa1AW96evc8JzWXGNL"},{"@type":"CROSSREF","@value":"10.1523/jneurosci.3996-13.2014_references_DOI_UZlFJxrp5wa1AW96evc8JzWXGNL"},{"@type":"CROSSREF","@value":"10.1111/j.1471-4159.2010.07029.x_references_DOI_UZlFJxrp5wa1AW96evc8JzWXGNL"},{"@type":"CROSSREF","@value":"10.1679/aohc.72.77_references_DOI_UZlFJxrp5wa1AW96evc8JzWXGNL"},{"@type":"CROSSREF","@value":"10.1016/j.jocn.2021.07.025_references_DOI_UZlFJxrp5wa1AW96evc8JzWXGNL"},{"@type":"CROSSREF","@value":"10.5692/clinicalneurol.cn-001131_references_DOI_UZlFJxrp5wa1AW96evc8JzWXGNL"}]}